AgiBot G2 and A2

1. 5

   Regulator-cleared or mass market

   A regulator has cleared it where approval applies: FDA clearance or approval for a medical robot, a permit to run with no one aboard for a self-driving vehicle, or an FAA approval for routine drone flights. Or: Widely sold: sales in the hundreds of thousands, or a product category you can buy in ordinary shops.

2. 4

   Paying customers

   Delivered to customers who pay for it, beyond a trial, or a paid service the public can use.

3. 3

   PilotThis robot

   Working with a named customer in a real setting, as a trial.

   Placed by: In a six-day livestreamed trial, G2 robots checked more than 17,000 tablets on a Longcheer factory line. AgiBot reported a 99.99% success rate (June 2026).

4. 2

   Pre-orders

   Orders, reservations or deposits taken, with nothing delivered yet.

5. 1

   Demo only

   Shown in videos, staged events or a factory, with no units working for customers.

What we couldn't confirm. Production counts (10,000th and 15,000th robots) are company figures and cover all AgiBot models, not just G2 and A2. No public price found from AgiBot itself. Caijing reported in Oct 2026 a new funding round of about Rmb 1bn to 1.5bn; not confirmed from a primary source.